baber/WOPTO huggingface dataset:
Patent EP-0747700-B1 (EP)
Inventor: WAGGONER ALAN STEWART
IPC: C09B56/16
Filed: 1996-05-30
Granted: 2001-12-05
Abstract: The present invention provides low molecular weight fluorescent labelling complexes with large wavelength shifts between absorption of one dye in the complex and emission from another dye in the complex. These complexes can be used, for example, for multiparameter fluorescence cell analysis using a single excitation wavelength. The low molecular weight of the complex permits materials labelled with the complex to penetrate cell structures for use as probes. The labelling complexes are synthesised by covalently attaching through linkers to form donor-acceptor complexes. Resonance energy transfer from an excited donor to fluorescent acceptor provides wavelength shifts up to 300nm. The fluorescent labelling complexes preferably contain reactive groups for the labelling of functional groups on target compounds, such as derivatised oxy and deoxy polynucleic acids, antibodies, enzymes, lipids, carbohydrates, proteins and other materials. The complexes may contain functional groups permitting covalent reaction with materials containing reactive groups.
Patent EP-0816559-B1 (EP)
Inventor: FARGEOUT PATRICK
IPC: B32B27/34
Filed: 1996-11-21
Granted: 2002-05-08
Abstract: An on-machine-seamable (OMS TM ) papermakers' fabric produced by modified endless weaving includes machine-direction (MD) and cross-machine direction (CD) yarns. The MD yarns are plied/twisted yarns, and weave continuously back-and-forth between the two widthwise edges of the fabric, each time forming a seaming loop at one of the two widthwise edges. A seaming spiral, a monofilament spiral preferably extruded from a polyamide resin, is attached to the seaming loops at each of the two widthwise edges. The two seaming spirals are used to join the fabric into endless form with a pin seam. In this way, an OMS TM  papermakers' fabric, having plied/twisted yarns in the machine direction is provided with monofilament joining means which maintain proper orientation and shape for the ready pin seaming of the fabric on a papermachine. <IMAGE>
Patent EP-0823049-B1 (EP)
Inventor: BALTRUSCHAT HELMUT
IPC: G01N27/26
Filed: 1996-04-26
Granted: 2001-10-24
Abstract: Processes and devices are disclosed for continuously detecting at least one substance in a gaseous or liquid mixture by means of a sensor electrode to which is applied a variable potential. In an alternative, the substances are concentrated at the surface of the sensor electrode, their concentration is determined by measuring the electrode capacity, the thus obtained measurement value is correlated with the substance and the substance. concentrated at the surface of the sensor electrode is then removed. In another alternative, one or several detection cycles are carried out. In each detection cycle, at least one substance is concentrated at the surface of the sensor electrode, the potential is brought to at least one potential characteristic of the electrochemical reaction of at least one substance, the resulting current is measured and the thus obtained measurement values are correlated with the substances.
Patent EP-0825871-B1 (EP)
Inventor: BIANCHI ROBERTO
IPC: A23L33/15
Filed: 1996-05-15
Granted: 2001-08-22
Abstract: PCT No. PCT/EP96/02079 Sec. 371 Date Dec. 9, 1997 Sec. 102(e) Date Dec. 9, 1997 PCT Filed May 15, 1996 PCT Pub. No. WO96/36348 PCT Pub. Date Nov. 21, 1996A pharmaceutical or dietetic composition or both a pharmaceutical and dietetic composition having antioxidant activity contains carnosine or derivatives of carnosine and leucine, isoleucine and valine. It may also contain other components such as carnitine, vitamins, oligoelements and bioflavanoids.
Patent EP-0837630-B1 (EP)
Inventor: HOSTETLER KARL Y
IPC: A61K31/7072
Filed: 1996-06-07
Granted: 2007-12-26
Abstract: Lipid prodrugs of pharmaceutical agents and their analogs that have increased anticancer, anti-viral, anti-inflammatory, anti-proliferative activity over the parent drug, and methods for making lipid prodrugs. Compositions comprising lipid prodrugs for treating disease and methods for treating disease which involve using the compositions.
Patent EP-0843734-B1 (EP)
Inventor: ANDERSON ROLFE C
IPC: C12M1/34
Filed: 1996-06-27
Granted: 2003-03-26
Abstract: The present invention provides a miniaturized nucleic acid diagnostic device and system (522). The device (522) of the invention is generally capable of performing one or more sample acquisition and preparation operations, in combination with one or more sample analysis operation. For example, the device (522) can integrate several or all of the operations involved in sample acquisition and storage, sample preparation and sample analysis, within a single integrated unit (522). The device (522) is useful in a variety of applications, and most notably, nucleic acid based diagnostic applications and de novo sequencing applications. <IMAGE>
Patent EP-0843647-B1 (EP)
Inventor: LANGLET ABRAHAM
IPC: C01B21/082
Filed: 1996-07-26
Granted: 2001-04-11
Abstract: PCT No. PCT/SE96/00976 Sec. 371 Date Jan. 13, 1998 Sec. 102(e) Date Jan. 13, 1998 PCT Filed Jul. 26, 1996 PCT Pub. No. WO97/06099 PCT Pub. Date Feb. 20, 1997The invention relates to a method of preparing dinitramidic acid HN(NO2)2 and salts thereof having the formula M+n(-N(NO2)2)n, wherein M is a metal cation or a nitrogen-containing cation and n=1-3. The dinitramide salt can be used as oxidiser in solid propellants. Dinitramidic acid is prepared by nitration of a compound selected from a group consisting of NH2NO2, NH4NH2CO2; NH2SO3H, NH(SO3H)2, N(SO3H)3, and its salts with metal cations or organic cations, e.g. NH(SO3NH4)2, and other products formed when ammonia is reacted with sulphuric trioxide, with a common nitrating acid such as nitric acid/sulphuric acid or nitric acid/acetic anhydride. The invention also relates to a method of preparing dinitramide salt, comprising neutralisation of dinitramidic acid with a neutralising agent, e.g. ammonia, and recovery of the dinitramide salt from a mixture of salts formed in the neutralisation. An aqueous solution of the salt mixture is passed through a column containing an adsorbing agent which adsorbs the dinitramide salt and is selected from a class consisting of activated carbon, silica gel and zeolites. The dinitramide salt is eluted with an elution agent consisting of hot water and/or a polar organic solvent, e.g. acetone, acetonitrile, 2-propanol and other lower alcohols and mixtures thereof.
Patent EP-0859632-B1 (EP)
Inventor: CHATFIELD STEVEN N
IPC: A61K39/39
Filed: 1996-11-01
Granted: 2002-03-20
Abstract: PCT No. PCT/GB96/02680 Sec. 371 Date Apr. 29, 1998 Sec. 102(e) Date Apr. 29, 1998 PCT Filed Nov. 1, 1996 PCT Pub. No. WO97/16208 PCT Pub. Date May 9, 1997The invention provides a vaccine composition in the form of a kit, comprising a first container containing an antigenic preparation comprising influenza antigen or antigens; and a second container containing an effective adjuvant amount of a chitosan which is a deacetylated chitin which is at least 80% deacetylated. The antigenic preparation in the first container preferably comprises haemagglutinin and neuraminidase influenza antigens.
Patent EP-0866678-B1 (EP)
Inventor: MARTIN GERALD RAY
IPC: A61F2/92
Filed: 1996-12-13
Granted: 2007-09-12
Abstract: This invention is a stent graft (2) including a stent member (6) having an inner surface and an outer surface, a generally tubular graft member (4) and a coupling member (8) that couples the stent member (6) to the graft member (4). The coupling member (8), which in the preferred embodiment is in the form of a ribbon, covers only a portion of the inner or outer surface of the stent member (6) and secures the stent member (6) and graft member (4) to one another. Alternatively, the coupling member (8) can be described as interconnecting less than entirely the inner or outer surface of the graft member (4) to the stent member (6). With this construction, regions of the stent member (6) do not interface with the coupling member (8). Shear stresses between the stent member (6) and the coupling member (8) and the risk of tearing the graft (4) or coupling member (8) or delamination therebetween may be reduced as compared to a fully enveloped stent member (6). This construction also provides improved flexibility and kink resistance.
Patent EP-0799894-B1 (EP)
Inventor: EFFENBERGER FRANZ
IPC: C07C253/00
Filed: 1997-01-30
Granted: 2004-05-19
Abstract: Preparation of (S)-cyanohydrin compounds of formula (I) comprises enzyme-catalysed reaction of carbonyl compounds of formula (II) with hydrocyanic acid, or a substance which releases hydrocyanic acid or CN, in the presence of a catalytic amount of an (S)-oxynitrilase immobilised on a nitrocellulose carrier. R, R' = H; 1-18C alkyl, 2-18C alkenyl or 2-18C alkynyl (all optionally substituted by ≥ 1 amine, imine, OH, 1-6C alkoxy, halo, carboxyl, 3-20C cycloalkyl and/or Het substituents, where the cyclic substituents are themselves optionally substituted by ≥ 1 halo, OH, 1-8C alkyl, 2-8C alkenyl or 2-8C alkynyl); or a (hetero)aromatic group containing 5-22 ring atoms, in which up to 4 ring C atoms may be replaced by N, O and/or S atoms, the ring being optionally substituted by ≥ 1 amine, imine, OH, 1-8C alkoxy, aryloxy, halo, carboxy or 1-22C optionally unsaturated alkyl, where ≥ 2 of the ring substituents may combine to form a cyclic group; Het = an aromatic ring with up to 22C atoms which is optionally substituted by N, O or S heteroatoms; provided that R' and R are not both H.
Patent EP-0816343-B1 (EP)
Inventor: HOLLA WOLFGANG DR
IPC: C07D233/76
Filed: 1997-06-16
Granted: 2005-12-14
Abstract: Preparation of chiral, non-racemic compounds of formula (I) comprises carrying out a racemate cleavage of the racemic compound (I) by forming its salt with a chiral, non-racemic amino compound. R1 = H, F, Cl, Br, I, CN, NO2 or OH; R2 = H, F, 1-7C alkyl, phenyl(1-7C)alkyl or 3-8C cycloalkyl. A process for the preparation of the precursor racemate (I) is also claimed.
Patent EP-0838145-B1 (EP)
Inventor: ROTH ANDREAS DIPL-ING
IPC: F16H1/14
Filed: 1997-09-06
Granted: 2001-05-09
Abstract: The angular gearing transmission, especially for use in agricultural machinery, has a housing of the first housing section (1) with a radial inner ring wall (5) or journal and a radially offset outer ring wall (8) connected by an end wall (10) to form a ring zone in relation to the first rotary axis (3). A second housing section (2), at an angle to the first section, has an outer wall (21) round its rotary axis (4) at an angle to the first axis, in a one-piece bond with the outer ring wall of the first housing section, with a passage (25) to the ring zone. A second end wall (22) is in one piece with the first end wall of the first housing section. The first bevel gear (11) is in the ring zone of the first housing section, with its teeth (14) towards the first end wall.
Patent EP-0846510-B1 (EP)
Inventor: BRUNGS DIETER DR ING
IPC: B22D21/00
Filed: 1997-11-27
Granted: 2001-05-23
Abstract: Casting method for extrusion billets of light metal or alloy, especially magnesium or magnesium alloy, with a diameter of 60 to 400 mm, using a tubular metal mould with an internal diameter or cross section corresponding to the required billet. Corresponding equipment is also claimed.
Patent EP-0830942-B1 (EP)
Inventor: LEWIS THOMAS E
IPC: B41C1/10
Filed: 1997-09-17
Granted: 2002-02-06
Abstract: Cleaning compositions for ablation-type lithographic printing plates include solvent, non-solvent and lubricating components, the vapor pressures and concentrations of the various components being chosen such that the mixture never becomes too rich in solvent. In this way, the solvent's effect is directed primarily at thermal byproducts, which, because they are exposed and already partly decomposed, are more vulnerable to solvent action than the intact, anchored plate constituents in unimaged regions. The compositions are used in conjunction with mechanical rubbing of the plate surface following imaging.
Patent EP-0876311-B1 (EP)
Inventor: WIDMER CHRISTIAN
IPC: C05F17/00
Filed: 1997-01-24
Granted: 1999-08-18
Abstract: PCT No. PCT/EP97/00341 Sec. 371 Date Jul. 27, 1998 Sec. 102(e) Date Jul. 27, 1998 PCT Filed Jan. 24, 1997 PCT Pub. No. WO97/27158 PCT Pub. Date Jul. 31, 1997A process and an apparatus for carrying out the process for the biological treatment of organic wastes. In order to achieve more effective treatment of the material, in a horizontally oriented reactor, a circulating agitator is disposed which causes circulation of the material with simultaneous advance. The material is leached via spray arms, with simultaneous intense aeration of the material to generate an aerobic biological degradation process.
Patent EP-0888480-B1 (EP)
Inventor: WOOD WILLARD E
IPC: B29C48/08
Filed: 1997-02-20
Granted: 2002-01-23
Abstract: Nonwoven cellulosic fiber webs such as, for example, paperboards and corrugated paper boards are described containing a barrier layer that can act both as a barrier to the passage of contaminants and as a trap for contaminant materials that can arise in new materials or from the recycle of fiber in the manufacture of paperboard. The effective material which acts as a trap or barrier is a cyclodextrin compound, substantially free of an inclusion complex compound. The cyclodextrin barrier layer can be corrugated or sheet laminated with or on the cellulosic web. Alternatively, the cyclodextrin material can be included in a coating composition that is coated on the surface or both surfaces of the cellulosic web after web formation. Further, the cyclodextrin material can be included in a thermoplastic film that can be used as one layer in a bilayer or multilayer laminate containing a cellulosic web.
Patent EP-0931115-B1 (EP)
Inventor: CRANDALL MICHAEL D
IPC: C08F2/44
Filed: 1997-02-24
Granted: 2002-06-05
Abstract: Composition adhésive de microsphères stabilisées comprenant une pluralité de microsphères polymères, élastomères. Ces microsphères sont le produit de réaction de réactifs comprenant des matériaux de départ polymérisables constitués par au moins un monomère de (méth)acrylate d'alkyle en C4-C14 et éventuellement par au moins un comonomère, au moins un additif insaturé de vinyle ayant à la fois une fraction ionique et une fraction hydrophobe et contenant au moins 5, mais pas plus de 40 atomes de carbone, dans une quantité d'environ 0,1 à 3 parties en poids de microsphères; éventuellement, un agent stabilisant polymère dans une quantité comprise entre environ 0,1 et environ 3 parties en poids pour 100 parties en poids de microsphères; un tensioactif dans une quantité ne dépassant pas environ 5 parties en poids pour 100 parties en poids de microsphères; éventuellement un agent modificateur qui représente au moins un agent de transfert de chaîne, un agent collant, un solvant ou autre dans une quantité suffisante pour produire des mmicrosphères avec une partie soluble de n-heptane dans une plage comprise entre 30 et 98 %, et (f) un initiateur dans une quantité effective permettant de catalyser la réaction de polymérisation présente dans des quantités comprises entre environ 0,1 et approximativement 2 parties en poids pour 100 parties en poids du matériau de départ polymérisable constitué d'un monomère.
Patent EP-1012795-B1 (EP)
Inventor: KAYANI SOHAIL
IPC: G07D7/182
Filed: 1997-10-10
Granted: 2002-07-17
Abstract: Measuring the limpness of a note is necessary to separate a worn note out of circulation. A method of measuring the limpness of a note is disclosed which measures the heat capacity of the note.
Patent EP-0870180-B1 (EP)
Inventor: DREVILLON BERNARD
IPC: G01J4/04
Filed: 1997-10-16
Granted: 2001-12-05
Abstract: An optical component for modulation of polarization, a Mueller polarimeter and ellipsometer containing such an optical component. The optical component modulates a linearly polarized incident beam and returns a modulated beam. It includes a coupled phase modulator which modulates the incident beam twice in succession, the two modulations having the same frequency of omega/2pi, and a coupling system modifying the polarization state of the light between the two modulations. The ellipsometer includes the means for detection of a measurement beam returned by a sample, which receives the modulated beam, in addition to a processing unit. The means of detection include a polarimeter producing n measured quantities representing the polarization states of the beam, and the processing unit produces m values for each of these quantities by Fourier transform, with nxm>=16 and m>=4, providing simultaneous access to the sixteen components of the Mueller matrix of the sample.
Patent EP-0930866-B1 (EP)
Inventor: DIEC KHIET HIEN
IPC: A61Q17/04
Filed: 1997-10-02
Granted: 2002-06-26
Abstract: Microemulsion gels a) based on water in oil type microemulsions, comprising an oil phase which is essentially composed of not easily volatile components, an aqueous phase containing one or more polyethoxylated W/O emulsifiers and/or one or more polypropoxylated W/O emulsifiers and/or one or more polyethoxylated and polypropoxylated W/O emulsifiers and/or one or more monoesters, diesters, polyesters of polyols as W/O emulsifiers and/or one or more monoethers, diethers, polyethers of polyols as W/O emulsifiers and/or one or more dimethicone copolyols as W/O emulsifiers and/or one or more fatty alcohols or fatty acids as W/O emulsifiers and/or one or more sorbitan esters as W/O emulsifiers and/or one or more methyl glucose esters as W/O emulsifiers, and also comprising if desired one or more O/W emulsifiers, obtained in such a way that a mixture of basic components comprising an aqueous phase, an oil phase, one or more inventive emulsifiers is produced, being the HLB value of the emulsifier or emulsifier combination located between 2 and 14.
Patent EP-0895981-B1 (EP)
Inventor: KAMIGAUCHI TOSHIYUKI
IPC: C07C43/23
Filed: 1997-04-11
Granted: 2001-02-07
Abstract: The present invention provides a compound of the formula (I): <CHEM> wherein R<1> is hydrogen or hydroxy and R<2> is hydroxy or methoxy, pharmaceutically acceptable salts or hydrates thereof, a process for producing the same, a pharmaceutical composition which comprises the same and a microorganism which belongs to Aspergillus candidus and produces the compound.
Patent EP-0842054-B1 (EP)
Inventor: SMITH MICHAEL JAMES
IPC: B44C7/00
Filed: 1997-05-02
Granted: 2000-07-05
Abstract: Paint is applied to a surface system as a wall using a paint application system comprising a releasable backing (10) formed of water-permeable paper having a water-release layer thereon. The system includes a decoration layer (12) and a transparent barrier layer (13) disposed between the decoration layer (12) and the releasable backing (10). The decoration layer (12) is formed of a dried paint composition, e.g. a dried aqueous emulsion paint, comprising one or more pigments in a polymeric binder. An adhesive layer (14) is disposed on an opposite side of the decoration layer (12) to the barrier layer (13). The adhesive layer (14) is engaged with the surface to be decorated by the decoration layer (12). The backing (10) is removed so as to enable the decoration layer (12) applied to said surface to be viewed through the barrier layer (13). The barrier layer (13) prevents the adhesive of the adhesive layer reaching an outer surface of the applied layers.
Patent EP-0907733-B1 (EP)
Inventor: DAVIS-SMYTH TERRI LYNN
IPC: C07K16/28
Filed: 1997-05-06
Granted: 2006-05-24
Abstract: The present invention is directed to novel chimeric VEGF receptor proteins comprising amino acid sequences derived from the vascular endothelial growth factor (VEGF) receptors flt-1 and KDR, including the murine homologue to the human KDR receptor FLK-1, wherein said chimeric VEGF receptor proteins bind to VEGF and antagonize the endothelial cell proliferative and angiogenic activity thereof. The present invention is also directed to nucleic acids and expression vectors encoding these chimeric VEGF receptor proteins, host cells harbouring such expression vectors, pharmaceutically acceptable compositions comprising such proteins, methods of preparing such proteins and to methods utilizing such proteins for the treatment of conditions associated with undesired vascularization.
Patent EP-0915911-B1 (EP)
Inventor: BARBIER JEAN-RENE
IPC: A61P19/10
Filed: 1997-08-01
Granted: 2003-10-29
Abstract: This invention describes analogues of human parathyroid hormone which have increased activities in bone restoration, and increased bioavailabilities. The peptides described are derivatives of hPTH-(1-31) which are cyclized for example, by formation of Lactams between either Glu<22> and Lys<26> or Lys<26> and Asp<30>. In addition, the natural Lys<27> may be substituted by either a Leu or other hydrophobic residues, such as Ile, norleucine, Met, Val, Ala, Trp, or Phe. Typically, these analogues have enhanced abilities to stimulate adenylyl cyclase in rat osteosarcoma cells, and show increased activities in bone restoration, using the ovariectomized rat model. The analogues also show enhanced activities and bioavailabilities, as demonstrated by their hypotensive effects in the rat. An assay which correlates hypotensive activity with osteogenic activity is also described.
Patent EP-0994799-B1 (EP)
Inventor: DURBAN JACK
IPC: B62B5/04
Filed: 1997-07-16
Granted: 2009-05-20
Abstract: An anti-theft vehicle system (10) for a vehicle wheel (12) having a rotational axis includes at least one inhibitor (24) disposed within the vehicle wheel to selectively engage and disengage the vehicle wheel to resist and allow rotational movement of the vehicle wheel about its rotational axis. The anti-theft vehicle system (10) also includes rotatable structure disposed within the vehicle wheel and cooperating with the at least one inhibitor for moving the at least one inhibitor between an engaged position and a disengaged position with respect to the vehicle wheel. The anti-theft vehicle system further includes a receiver (69) operatively associated with the vehicle wheel to receive a predetermined signal to activate the rotatable structure to move the at least one inhibitor between the engaged position and disengaged position.
Patent EP-0951850-B1 (EP)
Inventor: GRABSCH JOACHIM
IPC: A47C21/04
Filed: 1998-04-24
Granted: 2003-03-12
Abstract: A system of hollow cavities is provided in or adjacent to the support layer (7), extending over at least part of the top side of the mattress. The mattress includes a core (1) whose top side is formed by an essentially airtight cover layer (3) and a support layer comprising an elastically compressible material.
Patent EP-0884162-B1 (EP)
Inventor: PADOVANI PIETRO
IPC: B29C51/44
Filed: 1998-06-11
Granted: 2003-11-05
Abstract: A device for withdrawing and carrying away a moulding of thermoformed objects from a thermoforming single-station apparatus or press having a support frame, a feeder of sheet or tape material as well as a female die and a counterdie which are movably arranged one with respect to the other between a closed position in which the sheet or tape material fed by the feeder is thermoformed and an opened position in which the female die and the counterdie are mutually spaced apart one with respect to the other, the said plate device comprising driving means designed to move it along a straight path between a withdrawing position of the objects from the female die, while the latter is in its opened position and an object releasing position away from the die and guide means in the press arranged to engage and guide it at least along a lenght of the straight path thereof between the withdrawing and the releasing position, thereby preventing vibrations from being imparted to the plate during or immediately after withdrawal of the objects. <IMAGE>